Commercial by design
Every track ties technical and regulatory insight back to launch, access, partnering, or portfolio decisions.
The case for PARITY
Commercial outcomes demand more than a regulatory conversation. PARITY connects the people responsible for every decision between analytical similarity and patient access.
Why now
A projected $176 billion global market by 2034. More than 90 US approvals across 20 molecules. A new wave of exclusivity loss ahead.
That growth creates a new set of pressures. Developers need reliable manufacturing and differentiated market-entry plans. CDMOs need visibility into the programs coming next. Payers, regulators, and providers need workable approaches to adoption. Investors need to see where science can become durable value.
PARITY puts those connected questions in the same room.
Our difference
Every track ties technical and regulatory insight back to launch, access, partnering, or portfolio decisions.
Target attendance of 180–220 keeps the room senior, relevant, and navigable.
Pre-event profiles, requested matches, and dedicated meeting time turn introductions into a working agenda.
Who attends
From early analytical strategy to formulary placement and licensing, every decision-making function has a place at PARITY.
The promise
Come ready to test a strategy, find a partner, or place a bet on what comes next.
PARITY 2027 is produced by Synerg Events, organizers of NEURO-LOGIC, NULLIFY, and ADC NEXUS.